ABOS Acumen Pharmaceuticals: Net earnings per share (EPS TTM)
The EPS TTM fundamental metric reflects the profit dynamics of Acumen Pharmaceuticals (ABOS), which integrates ESG standards and bioethics into its fight against Alzheimer's, while the value of -1.54 serves as the current indicator. The development of this therapy will provide the company with exceptional pricing power. The operating model relies on digital oversight of external partners conducting global clinical trials.
Comprehensive metric breakdowns and analytics for Acumen Pharmaceuticals Inc. (ABOS)
- current quotes and average value forecast:
- company stock capitalization data:
- business book valuation details:
- debt and liquidity details:
Debt to Equity Acumen Pharmaceuticals|ABOS - Long-Term Liabilities to Equity|Short-Term Debt to Capital Acumen Pharma|ABOS - Aggregate Debt Obligations|Debts to Book Capitalization Acumen Pharmaceuticals, Inc.|ABOS - Company Long-Term Debts|Company Short-Term Debt Acumen Pharmaceuticals|Quick Liquidity acumenpharm.com
- earnings and multiples data:
ABOS - Net Income|Projected Future Earnings Acumen Pharmaceuticals|ABOS - P/E Multiple|Forward P/E Multiple Acumen Pharmaceuticals, Inc.|ABOS - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Acumen Pharmaceuticals, Inc.|ABOS - Profit before interest, taxes and amortization|Net earnings per share for the last 12 months Acumen Pharmaceuticals|ABOS - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months acumenpharm.com|ABOS - Net earnings per one share growth for the current year|Earnings growth forecast for next year Acumen Pharmaceuticals
General company analysis:Acumen Pharmaceuticals (ABOS)
Acumen Pharmaceuticals (ABOS) develops antibodies for Alzheimer's therapy, aiming for market dominance through its patent portfolio. The success of these developments directly impacts the net income distributed to shareholders. This metric measures actual management efficiency by stripping the total profit of the influence of the share issuance volume. Growth in this value confirms the fundamental stability of the business. The trend in the company's specific annual income allows for the timely identification of asset overvaluation.
Competitors of Acumen Pharmaceuticals (ABOS)
BIIB - Earnings per share for the last twelve months|neurocrine.com (NBIX) - Net earnings per share for the last 12 months|RGC: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Axsome (AXSM)|Earnings per share for the last twelve months ACADIA Pharmaceuticals Inc|Earnings per share for the last 12 months XENE (Xenon Corp)|Net earnings per share for the last 12 months VKTX (Viking Therapeutics)|SUPN (supernus.com) - Earnings per share for the trailing year|Earnings per share for the last twelve months Catalyst Pharmaceuticals, Inc. CPRX|DNLI (Denali) - Earnings per one share for the last 12 months|Harmony Pharma - Net earnings per share (EPS TTM)|Earnings per share for the trailing year BHVN (Biohaven Corp)|AMLX: Net earnings per share (EPS TTM)|trevitherapeutics.com (TRVI) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Praxis Precision Medicines, Inc.|AVXL: Earnings per share for the trailing year|Earnings per share for the last twelve months CeriBell Corp (CBLL)|Net earnings per share for the last 12 months Prothena Biosciences PRTA|Net earnings per share (EPS TTM) ALEC (Alector)|Net earnings per share (EPS TTM) annexonbio.com ANNX|Omeros Corp. - Net earnings per share (EPS TTM)|Neurogene Inc (NGNE) - Net earnings per share for the last 12 months|ACIU: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Voyager Corp (VYGR)|Net earnings per share for the last 12 months NMRA|Net earnings per share (EPS TTM) scilexholding.com|Net earnings per share for the last 12 months TVGN (Tevogen Bio)|Earnings per share for the last four quarters ACOG|Net earnings per share (EPS TTM) CGTX (Cognition Therapeutics)|Net earnings per share for the last four quarters Inhibikase Pharma (IKT)|Cassava Sciences, Inc. - Net earnings per share (EPS TTM)|Assertio Holdings, Inc. (ASRT) - Net earnings per share for the last 12 months|COYA: Net earnings per share (EPS TTM)|Vistagen (VTGN) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Ovid Therapeutics Inc|Earnings per share for the last twelve months CRVO|Earnings per share for the last twelve months Alterity Therapeutics (ATHE)|Net earnings per share for the last four quarters clene.com|Net earnings per share (EPS TTM) PEPG (PepGen)|Net earnings per share (EPS TTM) Jupiter Neurosciences, Inc. JUNS|Relmada - Net earnings per share (EPS TTM)|ANVS: Earnings per share for the last twelve months|gracetx.com (GRCE) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months fireflyneuro.com (AIFF)|Earnings per share for the last twelve months ANEW Medical|NeuroSense Therapeutics, Ltd. (NRSN) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Reviva Pharmaceuticals Holdings (RVPH)|metaviatx.com - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) NRXS (NeurAxis, Inc.)|Helius Medical Technologies, Inc. (HSDT) - Net earnings per one share for the last twelve months|PASG: Net earnings per share for the last 12 months|NEUP - Net earnings per share (EPS TTM)|Minerva Neurosciences Corp (NERV) - Earnings per share for the last twelve months|Athira Pharma Corp - Earnings per share for the trailing year|Earnings per share for the last twelve months Addex Therapeutics|Net earnings per one share for the last twelve months Alzamend ALZN|Net earnings per share (EPS TTM) CYCN|Net earnings per share (EPS TTM) protagenic.com (PTIX)|Net earnings per share (EPS TTM) KTTA (Pasithea Therapeutics Corp.)|CRGT - Net earnings per share for the last 12 months|ATXI: Net earnings per share for the last 12 months|BCLI - Net earnings per share (EPS TTM)|Cara Therapeutics (CARA) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Chromocell Therapeutics Corp|ELYM (Eliem Therapeutics, Inc.) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Intra-Cellular ITCI|Earnings per share for the last twelve months Longboard Pharmaceuticals (LBPH)|marinuspharma.com - Earnings per share for the last 12 months|NKGen Biotech - Net earnings per share for the last 12 months|Earnings per share for the trailing year NRBO|SAGE - Earnings per share for the last twelve months|Earnings per one share for the last 12 months SNPX|TRVN: Net earnings per share (EPS TTM)|Vigil Neuroscience, Inc. - Earnings per share for the trailing year|WENA (Anew Medical) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Cerevel Therapeutics Inc
